Abstract

Get full access to this article
View all access options for this article.
References
1.
Fahn
S
. Parkinsonism . In:
Wyngaarden
JB
Smith
LH
, eds. Cecil textbook of medicine . 18th ed . Philadelphia : WB Saunders , 1988 : 2143 –7 .
2.
Garver
DL
Davis
JM
. Biogenic amine hypotheses of affective disorders . Life Sci
1979 ; 24 : 383 –94 .
3.
Taylor
AE
Saint-Cyr
JA
Lang
AE
Kenny
FT
. Parkinson's disease and depression: A critical reevaluation . Brain
1986 ; 109 : 279 –92 .
4.
Starkstein
SE
Preziosi
TJ
Bolduc
PL
Robinson
RG
. Depression in Parkinson's disease . J Nerv Ment Dis
1990 ; 178 : 27 –31 .
5.
Mayeux
R
Stern
Y
Cote
L
Williams
BW
. Altered serotonin metabolism in depressed patients with Parkinson's disease . Neurology
1984 ; 34 : 642 –5 .
6.
Halaris
AE
Belendiuk
KT
Freedman
DX
. Antidepressant drugs affect dopamine uptake . Biochem Pharmacol
1975 ; 24 : 1896 –8 .
7.
Hurley
SC
. Tricyclic antidepressants-induced abnormal movements (drug consult) . In:
Gelman
CR
Rumack
BH
, eds. DRUGDEX information system . Denver : Micromedex (edition expired 5/90).
8.DRUGDEX editorial staff . Amoxapine (drug evaluation monograph) . In:
Gelman
CR
Rumack
BH
, eds. DRUGDEX information system . Denver : Micromedex (edition expired 5/90).
9.DRUGDEX editorial staff . Levodopa–tricyclic antidepressant interaction (drug consult) . In:
Gelman
CR
Rumack
BH
, eds. DRUGDEX information system . Denver : Micromedex (edition expired 5/90).
10.
Strang
RR
. Imipramine in treatment of parkinsonism: A double-blind placebo study . Br Med J
1965 ; 2 : 33 –4 .
11.
Laitinen
L
. Desipramine in treatment of Parkinson's disease . Acta Neurol Scand
1969 ; 45 : 109 –13 .
12.
Andersen
J
Aabro
E
Gulmann
N
Hjelmsted
A
Pedersen
HE
. Antidepressive treatment in Parkinson's disease: A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-dopa . Acta Neurol Scand
1980 ; 62 : 210 –9 .
13.
Thistlewaite
JR
Cosimi
AB
Delmonico
FL
, Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection . Transplantation
1984 ; 38 : 695 –701 .
14.
Colonna
JO
Goldstein
LI
Brems
JJ
, A prospective study on the use of monoclonal anti-T3-cell antibody (OKT3) to treat steroid-resistant liver transplant rejection . Arch Surg
1987 ; 122 : 1120 –3 .
15.
Gordon
RD
Tzakis
AG
Iwatsuke
S
, Experience with Orthoclone OKT3 monoclonal antibody in liver transplantation . Am J Kidney Dis
1988 ; 11 : 141 –4 .
16.
Rohrer
JR
Jenkins
RI
Khettry
U
, Histological response to OKT3 therapy for hepatic allograft rejection . Transplant Proc
1987 ; 19 : 2459 –61 .
17.
Starzl
TE
Fung
JJ
. Orthoclone OKT3 in treatment of allografts rejected under cyclosporine—steroid therapy . Transplant Proc
1986 ; 18 : 937 –41 .
18.
Macris
MP
Frazier
OH
Lammermeier
D
Radovancevic
B
Duncan
JM
. Clinical experience with muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation . J Heart Transplant
1989 ; 8 : 281 –7 .
19.Ortho Multicenter Transplant Study Group . A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants . N Engl J Med
1985 ; 313 : 337 –42 .
20.
Todd
PA
Brodgen
RN
. Muromonab-CD3: A review of its pharmacology and therapeutic potential . Drugs
1989 ; 37 : 871 –99 .
21.Aseptic meningitis among kidney transplant recipients receiving a newly marketed murine monoclonal antibody preparation . MMWR
1986 ; 35 : 551 –2 .
22.
Thistlewaite
JR
Gaber
BW
Haag
AJ
, OKT3 treatment of steroid-resistant renal allograft rejection . Transplantation
1987 ; 43 : 176 –84 .
23.
Emmons
C
Smith
J
Flanigan
M
. Cerebrospinal fluid inflammation during OKT3 therapy (letter) . Lancet
1986 ; 2 : 510 –1 .
24.
Roden
J
Klintmalm
GBG
Husberg
BS
Nery
J
Olsen
JM
. Cerebrospinal fluid inflammation during OKT3 therapy (letter) . Lancet
1987 ; 2 : 272 .
25.
Martin
MA
Massanari
RM
Nghiem
DD
Smith
JL
Corry
RJ
. Nosocomial aseptic meningitis associated with administration of OKT3 . JAMA
1988 ; 259 : 2002 –5 .
26.
Thistlewaite
JR
Stuart
JK
Mayes
JT
, Monitoring and complications of monoclonal therapy—complications and monitoring of OKT3 therapy . Am J Kidney Dis
1988 ; 11 : 112 –9 .
27.
Kormos
RL
Armitage
JM
Dummer
JS
Miyamoto
Y
Griffith
BP
Hardesty
RL
. Optimal perioperative immunosuppression in cardiac transplantation using rabbit antithymocyte globulin . Transplantation
1990 ; 49 : 306 –11 .
28.
Rello
J
Vallverdú
I
Coll
P
Gurguí
M
Net
A
. Aseptic meningitis associated with muromonab-CD3 (letter) . DICP Ann Pharmacother
1990
24 : 1233 .
29.
Miller
RA
Maloney
DG
McKillop
J
, In vivo effects of murine monoclonal antibody in a patient with T-cell leukemia . Blood
1981 ; 58 : 78 –86 .
30.
Williams
AF
Gagnon
J
. Neuronal cell Thy-l glycoprotein: Homology with immunoglobulin . Science
1982 ; 216 : 696 –703 .
31.
Birnbaum
G
. Studies on brain-thymus cross-reactive antigens . Brain Res
1975 ; 84 : 111 –21 .
